NCT05285059 Implicit Learning in Epileptic Children
| NCT ID | NCT05285059 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Epilepsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-03-21 |
| Primary Completion | 2027-03-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2023-03-21 with a primary completion date of 2027-03-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Epileptic children suffer from impairments in various learning and memory tasks. Yet, no study investigated implicit learning in epileptic children. Implicit learning is not only underlying motor skills acquisition, but also social and cognitive ones. Because acquisition of new skills is optimal during childhood, the study of implicit learning mechanism in children is of major importance. The present study will be the first to explore implicit learning mechanisms in children with epilepsy. Implicit learning mechanisms can be preserved or altered.
Eligibility Criteria
Inclusion Criteria: * For Patient group only: Children with epilepsy * For Control group only: Children without neurological, psychiatric or developmental impairments * For both groups: Parent or tutors agreement * For both groups: Affiliated to French social security Exclusion Criteria: * Neurological impairments unrelated to epilepsy * Psychiatric impairments unrelated to epilepsy * Developmental impairments unrelated to epilepsy
Contact & Investigator
Marcastel Agathe, PhD
PRINCIPAL INVESTIGATOR
Service d'Epileptologie Clinique, des Troubles du sommeil et de Neurologie fonctionnelle de l'enfant - Hôpital Femme Mère Enfant
Frequently Asked Questions
Who can join the NCT05285059 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 14 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05285059 currently recruiting?
Yes, NCT05285059 is actively recruiting participants. Contact the research team at Agathe.marcastel@chu-lyon.fr for enrollment information.
Where is the NCT05285059 trial being conducted?
This trial is being conducted at Bron, France, Bron, France, Bron, France.
Who is sponsoring the NCT05285059 clinical trial?
NCT05285059 is sponsored by Hospices Civils de Lyon. The principal investigator is Marcastel Agathe, PhD at Service d'Epileptologie Clinique, des Troubles du sommeil et de Neurologie fonctionnelle de l'enfant - Hôpital Femme Mère Enfant. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.